表紙:拡張期心不全の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版
市場調査レポート
商品コード
1093613

拡張期心不全の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版

Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

出版日: | 発行: GlobalData | ページ情報: 英文 204 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
拡張期心不全の臨床試験分析:試験フェーズ、試験ステータス、試験回数、エンドポイント、ステータス、スポンサータイプ、上位国別-2022年最新版
出版日: 2022年04月07日
発行: GlobalData
ページ情報: 英文 204 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、拡張期心不全の臨床試験に関して調査分析し、世界中で実施された上位国の試験回数およびその平均登録数の概要、地域、国(G7 & E7)、試験ステータス、試験フェーズ、スポンサータイプ、エンドポイントステータス別に臨床試験に関連する情報を提供しています。また関与する上位企業をレビューし、その企業に関連するすべての試験(試験のタイトル、フェーズ、およびステータス)を列挙しています。

目次

  • レポートガイダンス
  • 臨床試験の調査範囲
  • 臨床試験:地域別
  • 臨床試験と平均登録:国別
  • G7諸国における臨床試験:心臓血管の臨床試験に対する拡張期心不全の割合
  • G7諸国におけるフェーズ別の臨床試験
  • G7諸国における試験ステータス別の臨床試験
  • E7諸国における臨床試験:心臓血管の臨床試験に対する拡張期心不全の割合
  • E7諸国におけるフェーズ別の臨床試験
  • E7諸国における試験ステータス別の臨床試験
  • 臨床試験:フェーズ別
  • 進行中の試験:フェーズ別
  • 臨床試験:試験ステータス別
  • 臨床試験:エンドポイントステータス別
  • 一定期間にわたって募集された被験者
  • 臨床試験:スポンサータイプ別
  • 著名なスポンサー
  • 拡張期心不全治療薬の臨床試験に参加している主要企業
  • 著名な薬
  • 臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 情報源
図表

List of Tables

List of Tables

  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2022*
  • Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
  • Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
  • Diastolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2022*
  • Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
  • Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2022*
  • Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*
  • Diastolic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
  • Diastolic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
  • Diastolic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*
  • GlobalData Methodology
目次
Product Code: GDHC6868CTIDB

GlobalData's clinical trial report, "Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update" provides an overview of Diastolic Heart Failure Clinical trials scenario. This report provides top line data relating to the clinical trials on Diastolic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Clinical Trials by G7 Countries: Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Diastolic Heart Failure to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Diastolic Heart Failure Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source